• Регистрация
  • Вход
    • en
    • ru
    • uz
  • en
  • ru
  • uz
Регистрация Вход
  • Текущий выпуск
  • Архивы
    • О журнале
    • Отправка материалов
    • Редакционная шапка
    • Заявление о конфиденциальности
    • Контакты
Текущий выпуск Архивы
О журнале Отправка материалов Редакционная шапка Заявление о конфиденциальности Контакты
  1. Главная
  2. Найти

Найти

Расширенные фильтры
Опубликовано после
Опубликовано до

Результаты поиска

##search.searchResults.foundPlural##
  • DIFFERENTIATED OBSTETRIC MANAGEMENT OF FETAL HYDROCEPHALUS BASED ON INTEGRATED ASSESSMENT OF VENTRICULAR SYSTEM AND FETOPLACENTAL HEMODYNAMICS

    Yusupbayev R.B., Batirov F.N.

    Background: Fetal ventriculomegaly is one of the most frequent prenatal central nervous system findings and is commonly defined by an atrial width of the lateral ventricle of 10 mm or more. The term fetal hydrocephalus should be used more cautiously, mainly when ventricular dilatation reflects impaired cerebrospinal fluid circulation, progressive enlargement, or obstruction. Prognosis depends on the degree of ventricular dilatation, isolated or non-isolated status, progression over time, genetic or infectious etiology, and concomitant obstetric complications. Objective: To present a differentiated obstetric management approach for fetal ventriculomegaly/hydrocephalus based on integrated assessment of ventricular size, progression, associated anomalies, fetal growth, and fetoplacental Doppler parameters. Materials and Methods: A narrative review was performed using recent clinical guidelines, systematic reviews, meta-analyses, and cohort studies published mainly from 2018 to 2026. Priority was given to recommendations from the Society for Maternal-Fetal Medicine and the International Society of Ultrasound in Obstetrics and Gynecology, and to studies assessing prenatal imaging, genetic testing, fetal MRI, Doppler assessment, and perinatal outcomes. Results: The evidence supports a risk-stratified pathway. Isolated mild ventriculomegaly (10-12 mm) usually has a favorable prognosis after complete evaluation. Moderate ventriculomegaly (13-15 mm), severe ventriculomegaly (>15 mm), progressive dilatation, bilateral involvement, associated structural anomalies, abnormal fetal growth, and abnormal Doppler findings require intensified assessment, multidisciplinary counseling, and individualized delivery planning. Cerebroplacental ratio and umbilical artery Doppler should not replace neurosonography, but they may refine obstetric decision-making when placental insufficiency or fetal growth restriction is suspected. Conclusion: Differentiated obstetric management of fetal ventriculomegaly should combine detailed neurosonography, etiological evaluation, serial assessment of ventricular dynamics, fetal growth and Doppler surveillance, and postnatal neurological follow-up. Timing and mode of delivery should generally follow standard obstetric indications, except in cases complicated by severe fetal compromise, marked macrocephaly, or other maternal-fetal indications.

    198-203
    11-06-2026
    Читать далее
  • EPIDEMIOLOGICAL ASPECTS AND CLINICAL IMPORTANCE OF PLACENTAL INSUFFICIENCY AND FETAL GROWTH RESTRICTION (LITERATURE REVIEW)

    Iminova N.B., Abdurashidova Kh.B.

    Placental insufficiency (PI) remains one of the most critical complications of pregnancy, with profound implications for maternal and perinatal health. Despite global progress in maternal care, the incidence of PI has remained largely unchanged over the past decades. According to clinical observations, PI is detected in approximately 22-35% of pregnancies, while in high-risk groups-such as women with preeclampsia, chronic somatic disorders, intrauterine infections, or uterine malformations-the incidence increases to 45-77%.

    78-81
    31-10-2025
    Читать далее
1 - 2 из 2 результатов

Информация

  • Для читателей
  • Для авторов
  • Для библиотек

Последние публикации

  • Логотип Atom
  • Логотип RSS2
  • Логотип RSS1
TNMU Publishing

Мы объединяем исследователей, знания и технологии, чтобы ускорить развитие медицины и улучшить здоровье общества.

 

Навигация

Главная
Журналы
Конференции
Авторам
Рецензентам
Издательские услуги

Поддержка

Правила для авторов
Этика публикаций
О нас
Часто задаваемые вопросы
Обратная связь

Контакты

 
Узбекистан, г. Ташкент,
Алмазарский р-н, Шифокорлар, 21
 
(+998) 91 164 24 40
 
publishing@tnmu.uz
© Copyright 2026 TNMU Publishing All Rights Reserved | Developed by in Science | Site create by in Designer
Войти в систему
Central Asian Journal of Medicine
Войти в систему
* Обязательно
* Обязательно
Забыли пароль?
Запомнить меня
Регистрация